The DOI matches its Crossref record.
Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS)
Abstract
Since the 1990 NIH-sponsored conference on polycystic ovary syndrome (PCOS), it has become appreciated that the syndrome encompasses a broader spectrum of signs and symptoms of ovarian dysfunction than those defined by the original diagnostic criteria. The 2003 Rotterdam consensus workshop concluded that PCOS is a syndrome of ovarian dysfunction along with the cardinal features hyperandrogenism and polycystic ovary (PCO) morphology. PCOS remains a syndrome and, as such, no single diagnostic criterion (such as hyperandrogenism or PCO) is sufficient for clinical diagnosis. Its clinical manifestations may include: menstrual irregularities, signs of androgen excess, and obesity. Insulin resistance and elevated serum LH levels are also common features in PCOS. PCOS is associated with an increased risk of type 2 diabetes and cardiovascular events.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Diagnosis of PCOS was based on the presence of two out of three Rotterdam Criteria: ovulatory dysfunction presenting as irregular menstrual cycles or amenorrhea, clinical and/or biochemical hyperandrogenism, and ultrasound assessment of polycystic ovaries (≥12 antral follicles in one ovary or ovarian volume ≥ 10 mL) [7,21].”
From Dietary Patterns and Metabolic and Hormonal Parameters in Women with Suspected PCOS (2025) · cites this paper as [7]
In the citing paper
“Moran et al. [126] reported reduced testosterone levels following lifestyle intervention but found no effect on FAI (100 × total testosterone/SHBG), a more valid marker of hyperandrogenism [121].”
From Exercise, or exercise and diet for the management of polycystic ovary syndrome: a systematic review and meta-analysis (2019) · cites this paper as [121]
In the citing paper
“The 2023 international evidence-based PCOS guidelines [3] recommend that a PCOS diagnosis should be based on criteria adapted from the Rotterdam criteria [7]; thus, requiring at least two of (1) clinical/biochemical hyperandrogenism; (2) ovulatory dysfunction; and (3) polycystic ovaries on ultrasound (anti-Mullerian hormone can be used instead of ultrasound) [3].”
From Polycystic Ovary Syndrome and the Internet of Things: A Scoping Review (2024) · cites this paper as [7]
In the citing paper
“There is no single diagnostic test, different sets of diagnostic criteria are still used, individual diagnostic criteria lack clarity, and exclusion of other etiologies is needed to establish the diagnosis of PCOS (4, 23, 24).”
From Delayed Diagnosis and a Lack of Information Associated With Dissatisfaction in Women With Polycystic Ovary Syndrome (2016) · cites this paper as [4]
In the citing paper
“There is no single diagnostic test, different sets of diagnostic criteria are still used, individual diagnostic criteria lack clarity, and exclusion of other etiologies is needed to establish the diagnosis of PCOS (4, 23, 24).”
From Delayed Diagnosis and a Lack of Information Associated With Dissatisfaction in Women With Polycystic Ovary Syndrome (2016) · cites this paper as [4]
4 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Still being checked.
Cited by
Endocrine-Disrupting Chemicals: An Endocrine Society Scientific Statement
Diamanti-Kandarakis, E., Bourguignon, J.-P., Giudice, L. C., Hauser, R., Prins, G. S., Soto, A. M., Zoeller, R. T., & Gore, A. C. (2009) · Endocrine Reviews · doi:10.1210/er.2009-0002 · Cited by 4,585
Azziz, R., Carmina, E., Dewailly, D., Diamanti-Kandarakis, E., Escobar-Morreale, H. F., Futterweit, W., Janssen, O. E., Legro, R. S., Norman, R. J., Taylor, A. E., et al. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-0178 · Cited by 2,143
Azziz, R., Carmina, E., Dewailly, D., Diamanti-Kandarakis, E., Escobar-Morreale, H. F., Futterweit, W., Janssen, O. E., Legro, R. S., Norman, R. J., Taylor, A. E., et al. (2009) · Fertility and Sterility · doi:10.1016/j.fertnstert.2008.06.035 · Cited by 2,132
Polycystic Ovary Syndrome: Definition, Aetiology, Diagnosis and Treatment
Escobar-Morreale, H. F. (2018) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2018.24 · Cited by 2,083
Fauser, B. C. J. M., Tarlatzis, B. C., Rebar, R. W., Legro, R. S., Balen, A. H., Lobo, R., Carmina, E., Chang, J., Yildiz, B. O., Laven, J. S. E., et al. (2012) · Fertility and Sterility · doi:10.1016/j.fertnstert.2011.09.024 · Cited by 1,976
Metadata
- Authors
- The Rotterdam ESHRE/ASRM-sponsored PCOS consensus workshop group
- Corresponding author
- The Rotterdam ESHRE/ASRM-sponsored PCOS consensus workshop group
- Venue
- Human Reproduction
- Publisher
- Oxford University Press (OUP)
- Published
- 2004-01-01
- Volume
- 19
- Issue
- 1
- Pages
- 41-47
- ISSN
- 0268-1161 (ISSN-L)
- 1460-2350
- OpenAlex
- W4256605237
- Cited by
- 6,138
- References
- 0
- Citations by year
- 2026: 346 · 2025: 412 · 2024: 472 · 2023: 434 · 2022: 419 · 2021: 395 · 2020: 342 · 2019: 326 · 2018: 263 · 2017: 265 · 2016: 226 · 2015: 259 · 2014: 266 · 2013: 249 · 2012: 232
- FWCI
- 76.91
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Human Reproduction (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
- Health Sciences › Medicine › Reproductive Medicine › Endometriosis Research and Treatment
- Health Sciences › Medicine › Reproductive Medicine › Reproductive Biology and Fertility
- Keywords
- polycystic ovary syndrome, diagnostic criteria, hyperandrogenism, polycystic ovary morphology, ovarian dysfunction, menstrual irregularity, insulin resistance, luteinizing hormone, type 2 diabetes risk, cardiovascular risk, obesity
- MeSH terms
- Clinical Trials as Topic, Consensus Statements as Topic, Female, Humans, Insulin Resistance, Luteinizing Hormone, Polycystic Ovary Syndrome, Risk Factors, United States, Consensus Development Conferences, NIH as Topic, Hyperandrogenism
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). https://app.cochat.ai/papers/10.1093/humrep/deh098
- The paper
- The Rotterdam ESHRE/ASRM-sponsored PCOS consensus workshop group. (2004). Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Human Reproduction. https://doi.org/10.1093/humrep/deh098
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.